PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsFrancis Collins steps down as NIH director after 12 years

BioNews

Francis Collins steps down as NIH director after 12 years

Published 17 December 2021 posted in News and appears in BioNews 1126

Author

Francesca Gavins

PET BioNews

Former head of the Human Genome Project, physician and geneticist, Francis Collins has resigned from his role of the head of the US National Institutes of Health in Bethesda, Maryland...

Former head of the Human Genome Project, physician and geneticist, Dr Francis Collins has resigned from his role of the head of the US National Institutes of Health (NIH) in Bethesda, Maryland.

Collins has spent more than 12 years heading the NIH, the world's biggest public funder of biomedical research. He will now return to run his laboratory full-time in the National Human Genome Research Institute, his first position in the NIH, which he led from 1993-2008. His two main projects are studying the genomics and epigenomics of type 2 diabetes and progeria, a rare disease that causes premature ageing.

'I did not expect to remain as NIH director for three presidents' he said to the journal JAMA. 'Twelve years is a long time, and I really wanted to be sure that I was not outlasting my shelf life here. I did a retreat on my own on a weekend at the end of May to try to figure out the right thing to do. I think scientific organisations need new leadership on a regular basis with new vision, and this was getting to be a pretty long haul.'

His proudest achievements in the role were the creation of the BRAIN Initiative, funding projects that map neural circuits in different organisms; the Precision Medicine Initiative that founded the largest ever longitudinal cohort study of health and disease called All of Us; and the National Center for Advancing Translational Sciences that focuses on translating basic science to clinical advances. In addition, he is proud of the rapid development of COVID-19 vaccines by the scientific community.

Recently, Collins has focused on addressing structural racism through the group UNITE, misinformation in science and the politicisation of science.

Collins supports the formation of a new NIH agency – the Advanced Research Projects Agency for Health – that aims to accelerate research by investing significant funds in high-risk projects and encouraging multiple collaborators. He encourages the next NIH director to invest time in interacting with Congress, becoming an expert of multiple areas and work with a team of bright, smart and visionary individuals.

Lawrence Tabak, the principal deputy director of the NIH, will serve as the acting director from 20 December 2021 until a suitable candidate is found. Tabak, a dentist and biochemist, supervises a laboratory at the National Institute of Dental and Craniofacial Research that investigates glycoprotein. According to Collins, Tabak 'has been my right arm for pretty much my entire time as NIH director'.

Sources and References

  • 20/12/2021
    Nature
    Science misinformation alarms Francis Collins as he leaves top NIH job
  • 01/12/2021
    JAMA Network
    After 12 years, NIH director Francis S Collins seeks his next chapter
  • 09/12/2021
    Science
    NIH director Francis Collins to hand reins to acting director Lawrence Tabak on 20 December

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 October 2021 • 2 minutes read

American organisations join together to develop gene therapies

by David Cansfield

The National Institutes for Health, Food and Drug Administration and 15 pharmaceuticals and non-profit organisations have joined together to accelerate the development of gene therapies in the USA...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 October 2019 • 2 minutes read

Gates Foundation and NIH pledge $200 million for gene therapies

by Dr Rosie Morley

The Bill and Melinda Gates Foundation has teamed up with the National Institutes of Health (NIH), the US national science funding body, to pledge US$100 million each over four years towards development of gene therapies for HIV and sickle cell anaemia...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
30 November 2018 • 6 minutes read

Genome editing in humans could become both ethical and prudent if properly regulated

by Professor John Harris

The announcement that Chinese scientists had genetically edited two embryos resulting in genome-edited human babies has occasioned outrage. My first reaction is that this action (if true) is both premature and reckless...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
17 August 2018 • 2 minutes read

Special rules for US gene therapy trials relaxed

by Rikita Patel

US gene therapy trials will now be treated like other clinical trials, as the National Institutes for Health step back from regulating them...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Embryo-like complexes generated from mouse stem cells

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856